Financial Information

SEC Filings

Filing date	Form	Description	Filing Group	View
Feb 09, 2024	UPLOAD	UPLOAD	Other	0000000000-24-001616.pdf 0000000000-24-001616.rtf View HTML
Feb 01, 2024	F-3	Registration statement for certain foreign private issuers offered for certain transactions	Registration Statements	0001213900-24-009108.pdf 0001213900-24-009108.rtf 0001213900-24-009108.xls View HTML
Jan 22, 2024	D	Notice of Exempt Offering of Securities	Other	0001213900-24-005073.pdf 0001213900-24-005073.rtf 0001213900-24-005073.xls View HTML
Jan 05, 2024	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-24-001325.pdf 0001213900-24-001325.rtf 0001213900-24-001325.xls View HTML
Nov 08, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-084500.pdf 0001213900-23-084500.rtf 0001213900-23-084500.xls View HTML
Nov 07, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-083999.pdf 0001213900-23-083999.rtf 0001213900-23-083999.xls View HTML
Oct 11, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001013762-23-002976.pdf 0001013762-23-002976.rtf 0001013762-23-002976.xls View HTML
Oct 10, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001013762-23-002826.pdf 0001013762-23-002826.rtf 0001013762-23-002826.xls View HTML
Oct 10, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001013762-23-002839.pdf 0001013762-23-002839.rtf 0001013762-23-002839.xls View HTML
Sep 20, 2023	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Current Reports	0001213900-23-077877.pdf 0001213900-23-077877.rtf 0001213900-23-077877.xls View HTML

Data provided by Kaleidoscope.

Technology

PolyPid’s PLEX targeted drug delivery platform enables localized, controlled, continuous release of medication over prolonged periods of time for better patient outcomes.

D-PLEX₁₀₀

Provides safe and effective local antibiotic protection against SSI (surgical Site Infection) at the needed tissues or organs by administration during surgical procedures.

D-PLEX₁₀₀₀

Comprised of antibiotic eluting ß tri-calcium phosphate (ßTCP) granules, designed for bone related infections applications.